Denmark

Loading...

DKK overview

PairLatest rateToday's change1 year change
DKKGBP0.1161
GBP
-0.0006 / -0.52%0.0034 / 2.99%
Today
0.1119May 29 20250.1187Nov 14 2025
DKKEUR0.1338
EUR
0.00002 / 0.02%-0.0002 / -0.17%
Today
0.1333Mar 23 20260.1348Jun 23 2025
DKKUSD0.156
USD
0.0005 / 0.32%0.0064 / 4.28%
Today
0.1497May 19 20250.1618Jan 27 2026
DKKJPY24.77
JPY
0.0802 / 0.32%2.98 / 13.70%
Today
21.59May 23 202525.15Apr 17 2026
DKKAUD0.2175
AUD
0.00008 / 0.04%-0.0162 / -6.92%
Today
0.2155May 13 20260.2433Aug 21 2025
DKKCAD0.2143
CAD
0.0005 / 0.23%0.0054 / 2.56%
Today
0.2083May 29 20250.2205Oct 17 2025
DKKCNY1.06
CNY
0.0016 / 0.15%-0.0176 / -1.63%
Today
1.06May 18 20261.06May 18 2026
DKKCHF0.1223
CHF
-0.00007 / -0.06%-0.0031 / -2.45%
Today
0.1202Mar 09 20260.1266Aug 18 2025

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of Denmark in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of May 19 2021.

Market movers

Constituents of the OMX Copenhagen 20 with the highest percent gain over one day.
ListingLastChangeVolume
FLSmidth & Co A/SFLS:CPH482.60
DKK
+25.60
+5.60%
197.12k
Vestas Wind Systems A/SVWS:CPH199.00
DKK
+8.10
+4.24%
3.08m
Tryg A/STRYG:CPH155.60
DKK
+5.20
+3.46%
1.04m
Pandora A/SPNDORA:CPH530.20
DKK
+14.00
+2.71%
613.64k
Coloplast A/SCOLO B:CPH404.30
DKK
+10.00
+2.54%
702.34k
Oersted A/SORSTED:CPH165.70
DKK
+3.15
+1.94%
3.00m
AP Moeller - Maersk A/SMAERSK A:CPH14,560.00
DKK
+140.00
+0.97%
2.43k
Zealand Pharma A/SZEAL:CPH312.60
DKK
+2.00
+0.64%
519.15k
AP Moeller - Maersk A/SMAERSK B:CPH14,770.00
DKK
+75.00
+0.51%
15.58k
Genmab A/SGMAB:CPH1,690.50
DKK
+6.50
+0.39%
57.42k
Data delayed at least 15 minutes, as of May 18 2026 14:30 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.